Serum Biomarkers Of Hypoxic-Ischemic Brain Injury
Physiological Research · 31.12.2023 · (Suppl. 5)
DOI: 10.33549/physiolres.935214 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Physiological Research, online erschienen am 31.12.2023. Verfasst von A Tefr Faridová und 4 weiteren Autor:innen. Beteiligte Einrichtung: A. Tefr Faridová, Department of Pathophysiology, Second Faculty of Medicine, Charles University, Prague 5, Czech Republic. adela.tefr-faridova@lfmoto…. Hauptthemen laut MEDLINE: Hypoxia-Ischemia, Brain, Brain Injuries. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Brain injury is a multifaceted condition arising from nonspecific damage to nervous tissue. The resulting cognitive developmental impairments reverberate through patients' lives, affecting their families, and even the broader economic landscape. The significance of early brain injury detection lies in its potential to stave off severe consequences and enhance the effectiveness of tailored therapeutic interventions. While established methods like neuroimaging and neurophysiology serve as valuable diagnostic tools, their demanding nature restricts their accessibility, particularly in scenarios such as small hospitals, nocturnal or weekend shifts, and cases involving unstable patients. Hence, there is a pressing need for more accessible and efficient diagnostic avenues. Among the spectrum of brain injuries, hypoxic-ischemic encephalopathy stands out as a predominant affliction in the pediatric population. Diagnosing brain injuries in newborns presents challenges due to the subjective nature of assessments like Apgar scores and the inherent uncertainty in neurological examinations. In this context, methods like magnetic resonance and ultrasound hold recommendations for more accurate diagnosis. Recognizing the potential of serum biomarkers derived from blood samples, this paper underscores their promise as a more expedient and resource-efficient means of assessing brain injuries. The review compiles current insights into serum biomarkers, drawing from experiments conducted on animal models as well as human brain pathologies. The authors aim to elucidate specific characteristics, temporal profiles, and the available corpus of experimental and clinical data for serum biomarkers specific to brain injuries. These include neuron-specific enolase (NSE), ubiquitin carboxy-terminal hydrolase L1 (UCH-L1), S100 calcium-binding protein beta (S100B), glial fibrillary acidic protein (GFAP), and high-mobility-group-protein-box-1 (HMGB1). This comprehensive endeavor contributes to advancing the understanding of brain injury diagnostics and potential avenues for therapeutic intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- A. Tefr Faridová, Department of Pathophysiology, Second Faculty of Medicine, Charles University, Prague 5, Czech Republic. adela.tefr-faridova@lfmotol.cuni.cz and jakub.otahal@lfmotol.cuni.cz
Zitieren
APA
Tefr Faridová, A., Heřman, H., Danačíková, Š., Svoboda, J., & Otáhal, J. (2023). Serum Biomarkers Of Hypoxic-Ischemic Brain Injury. Physiological Research. https://doi.org/10.33549/physiolres.935214
Vancouver
Tefr Faridová A, Heřman H, Danačíková Š, Svoboda J, Otáhal J. Serum Biomarkers Of Hypoxic-Ischemic Brain Injury. Physiological Research. 2023. doi:10.33549/physiolres.935214
BibTeX
@article{TefrFaridov2023,
author = {Tefr Faridová, A and Heřman, H and Danačíková, Š and Svoboda, J and Otáhal, J},
title = {Serum Biomarkers Of Hypoxic-Ischemic Brain Injury},
journal = {Physiological Research},
year = {2023},
number = {Suppl. 5},
doi = {10.33549/physiolres.935214}
}
EUVIMED